New rumors surfaced concerning COVID distribution and production.

The way mRNA vaccines are made allows same lines and factories to be used to produce COVID RNA or any similar RNA.

The new stage is production of virus outside shell and spike proteins and it is more complex compared to mRNA vaccine shell.

Rumors suggest that companies use genetically modified bacteria and already made RNA to quickly produce huge amount of virus.

Initially RNA is being put in already produced mRNA like shell to be able to go inside bacteria, and inside due to modified DNA bacteria recognize virus RNA and by itself signal RNA to bend as it is inside the virus and forms outside shell and spike proteins.

This also directly explains timing and amount of COVID waves as during spring they had only initial batches and few lines ready for production and companies needed months before October to finally tune and sometimes build vaccine production facilities. Such way October-December big wave had been made. Now in EU and US we have next wave that is being fed from even larger facilities.

Researcher of the Department of Immunology of the Scientific Research Institute of Physical and Chemical Biology of Moscow State University Andrei Kruglov developed a new method for detecting antibody responses to viral proteins and studied the cause of the severe course of the disease that occurs during new coronavirus infection.

Cytokine storms are actively discussed as the main cause of the severe course of the disease that occurs in patients with coronavirus infection. This is a situation when too many pro-inflammatory cytokines are produced - peptide molecules that alert the human body to danger. Proinflammatory cytokines act as a stimulator of immune responses to eliminate infectious pathogens, which leads to an excessively violent activation of inflammation and immunopathology. The use of blockers of this excessive inflammation helps only a few people with severe COVID-19.

Andrei Kruglov, a researcher at the Moscow State University Research Institute of Physical Chemistry, developed a new method for detecting the antibody response to viral proteins. It turned out that in severe COVID-19 patients, the antibody response switches, and in the later stages of the disease, immunoglobulin A (IgA2), which is not specific to the virus, begins to be produced. This is due to the fact that in the severe course of the disease, there is a large release of a suppressor molecule, a cytokine, TGF-b1.

“The significance of this work lies in the fact that the severe course of COVID-19 is not associated with a cytokine storm, but with the induction of a more complex pattern of cytokines, including those with immunosuppressive activity, which suppress the body's specific defense against the virus. Thus, our study offers a new way of treating severe COVID-19 by blocking TGFb1, ”concluded Andrey Kruglov.

The authors point out that, while in the usual case, plasmablasts secreting antibodies can be detected in the blood about 7 days after the onset of an acute immune response and only within 1-2 days, in the case of a severe form of COVID-19, their release was detected in during the entire duration of therapy (up to 60 days), which is also typical for autoimmune diseases mediated by antibodies. The transforming growth factor TGF-β is said to be the source of this reaction.

This TGF-β is also indicated as one of the important factors in cancer, cardiovascular disease (atherosclerosis), and renal failure.

The Taiwan Foreign Trade Development Board (TAITRA) has announced that it will not host Computex 2021 in its usual physical format. Despite the efforts of the organizers, the COVID-19 pandemic does not allow the event to be held in the form in which it was previously planned.

In December 2020, it was announced that the upcoming Computex should take place in regular face-to-face mode. A new statement from the organizers says the pandemic is preventing many participants and media representatives from taking part in the usual format of the event, so it makes no sense to hold it.

Nevertheless, the organizers of the exhibition are not going to completely cancel Computex 2021. The event is still scheduled to start on May 31, but the event itself will be digital.

Rosselkhoznadzor scientists have developed a COVID-19 vaccine for animals.

Mass production of the vaccine may begin in April. It will be produced in packages for 1, 50, 100 and 200 doses.

Clinical trials of the vaccine began in October 2020, the drug was tested on dogs, cats, arctic foxes, minks, foxes and other animals. According to Savenkov, animals have developed antibodies to coronavirus in 100% of cases.

This shows that despite media failed their mission to make enemies from our cats - all stuff had been prepared and new attack will start soon.

Also note that data prove that dogs will be also attacked.

Reducing contact of people with their cats and dogs and making them think mainly as source of danger is very important now.